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Abstract
Plasmodium vivax is the most widely distributed human parasite and the main cause of
human malaria outside the African continent. However, the knowledge about the genetic
variability of P. vivax is limited when compared to the information available for P. falciparum.
We present the results of a study aimed at characterizing the genetic structure of P. vivax
populations obtained from pregnant women from different malaria endemic settings.
Between June 2008 and October 2011 nearly 2000 pregnant women were recruited during
routine antenatal care at each site and followed up until delivery. A capillary blood sample
from the study participants was collected for genotyping at different time points. Seven P.
vivaxmicrosatellite markers were used for genotypic characterization on a total of 229 P.
vivax isolates obtained from Brazil, Colombia, India and Papua New Guinea. In each popu-
lation, the number of alleles per locus, the expected heterozygosity and the levels of multilo-
cus linkage disequilibrium were assessed. The extent of genetic differentiation among
populations was also estimated. Six microsatellite loci on 137 P. falciparum isolates from
three countries were screened for comparison. The mean value of expected heterozygosity
per country ranged from 0.839 to 0.874 for P. vivax and from 0.578 to 0.758 for P. falcipa-
rum. P. vivax populations were more diverse than those of P. falciparum. In some of the
studied countries, the diversity of P. vivax population was very high compared to the
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respective level of endemicity. The level of inter-population differentiation was moderate to
high in all P. vivax and P. falciparum populations studied.
Introduction
In endemic areas where Plasmodium vivax predominates, malaria in pregnancy is associated
with detrimental effects on the health of the affected mothers and their infants [1–8]. Yet, there
are still many gaps in the understanding of the mechanisms involved in the pathology of P.
vivax infection in pregnancy. Genetic diversity in the Plasmodium populations is reported to
be associated with the intensity of transmission. In P. falciparum, the genetic diversity is often,
but not always, directly associated with transmission intensity [9–12]; in P. vivax the situation
is more complicated and a number of studies reported high genetic diversity in parasite popula-
tions from low transmission settings [9,11,13–16]. As with Plasmodium falciparum, to under-
stand the epidemiology, diversity, distribution and transmission dynamics of natural P. vivax
populations in different epidemiological regions is crucial to develop specific control tools that
target the distinctive biology of this neglected parasite. With malaria elimination back on the
global agenda, mapping of global and local P. vivax population structure is essential prior to
establishing goals for elimination and the roll out of interventions [17].
In recent years, reliable methods to genotype populations of P. falciparum and P. vivax have
been developed. Genotyping methods based on the analysis of the polymorphic genes encoding
antigens under immune selective pressure [18–20] might lead to a misunderstanding of the
effective process of transmission [21]. Microsatellite (MS) markers, which are neutral or nearly
neutral genetic markers, showed a high degree of allelic variation [22, 23] and are efficiently
used for studies on genetic diversity and structure of both P. falciparum [24,25] and P. vivax
populations [26]. Moreover, the use of MS markers can improve the capability to distinguish
recrudescences/relapses from new infections in clinical trials [27].
The knowledge about the genetic variability of P. vivax is limited when compared to the
information available for P. falciparum. Recent studies show that P. vivax parasites exhibit
greater genetic diversity than P. falciparum, which suggests a greater functional variation, a dis-
tinct background of global colonization, and a more stable demographic history for P. vivax
compared to P. falciparum [9, 11, 28–30]. Studies on malaria in pregnancy in Colombia and
Thailand have recently shown that P. vivax parasites exhibited a high genetic diversity with
similar level of expected heterozygosity in both pregnant and non-pregnant women as well as
in symptomatic and asymptomatic infections [31, 32].
Here we present the results of a study that aimed to characterize the genetic structure of P.
vivax populations obtained from pregnant women from four countries with different malaria
endemic settings. Parasite isolates from three P. falciparum coendemic populations collected in
pregnant women and P. vivax isolates from non-pregnant women collected in Brazil were also
genotyped for comparison.
Methods
Ethics statement
Informed written consent was obtained from all subjects or their parents or guardians at the
time of recruitment. The study protocol was reviewed and approved by the national and/or
local ethics review boards in each of the sites, by the Institutional Review Board (IRB) of the
Centers for Disease Control and Prevention (CDC), and by the Hospital Clínic of Barcelona
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Ethics Review Committee (CEIC). The study was conducted in accordance with the Good Clin-
ical Practice Guidelines, the Declaration of Helsinki, and local rules and regulations of each
partner country. The name of ethics review committees/boards at each study site and, when
available, the respective approval numbers are listed as follows: Brasil-Comitê de Ética e Pes-
quisa da Fundação de Medicina Tropical do Amazonas, 0408/2008-FMT-AM, Comitê Nacio-
nal de Ética (CONEP), Brasilia, 0046.1.1144.000.08; Colombia -Comité Institucional de
Revisión de Ética Humana. Facultad de Salud. Universidad del Valle. Cali, Colombia, 022–07;
Guatemala-Comité de Ética, Universidad del Valle de Guatemala, Guatemala (no approval
number assigned to the protocol); India-Ethics Committee Sandar Patel Medical College. Bika-
ner, Rajasthan, India (no approval number assigned to the protocol); Papua New Guinea
(PNG)-PNG Institute of Medical Research Review Board, Madang, PNG, IRB 0815 MRAC
08.01.
Study population and study areas
This study was conducted in the context of the PregVax project (FP7-HEALTH-Project Grant
no. 201588), aimed at describing the burden and impact of P. vivax infection in pregnancy in
five endemic areas (Brazil, Colombia, Guatemala, India and Papua New Guinea) of different
malaria endemicity characteristics. The level of malaria transmission varied across study sites
from hypoendemic in Guatemala, India and Colombia, mesoendemic in Brazil, to hyperen-
demic in Papua New Guinea. P. vivax was the predominant species in all sites except for Papua
New Guinea where P. vivax co-existed with P. falciparum (50%) and other species (P.malariae
and P. ovale, 5%) (S1 Table).
Between June 2008 and October 2011 a cohort of nearly 2000 pregnant women were
recruited at each site at recruitment visit, coinciding with an ANC visit, in two subsequent
scheduled ANC visits one month apart and at delivery (the study sites for each country are
shown in Fig 1).
A capillary blood sample was collected for Plasmodium infection determination by micros-
copy and by real time PCR method [33] from all study women. At delivery, placental blood,
cord blood and newborn heel pricked blood samples were also collected (PregVax study group,
unpublished data). The samples obtained from the Guatemala study area showed submicro-
scopic/very low parasitaemia. Because of this, very limited amount of DNA template was avail-
able to carry out further experiments, and therefore no data on MSs analyses were available to
be included in the present study.
A total of 315 blood samples from P. vivax and P. falciparum infected pregnant women
from Brazil, Colombia, India and Papua New Guinea were processed for genotyping.
Fifty-one samples from non-pregnant women were also collected in the community among
women of reproductive age in Brazil. S2 Table summarizes the baseline characteristics of
patients analyzed in our study.
DNA extraction and microsatellite genotyping
Peripheral blood samples were spotted onto filter paper and analyzed at a centralized labora-
tory at the Istituto Superiore di Sanità in Rome, Italy, for Plasmodium determination by real
time PCR method (PregVax multicenter study, unpublished data). A total of 229 P. vivax and
137 P. falciparum isolates from infected women were genotyped. DNA was extracted using
PureLink Genomic DNA Kit (Invitrogen) following the manufacturer’s instructions. Seven P.
vivax and six P. falciparumMSmarkers were used for the genotypic characterization of the
field isolates (S3 Table). MS loci MS1, MS2, MS3, MS7, MS8, MS10 and MS20 were PCR-
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amplified from P. vivax isolates using labelled primers described by Karunaweera et al. 2007
[26].
The MSs Poly-α, TA60, Pfg377, PfPK2, TA87, TA109 were typed on P. falciparum positive
samples as previously described [34], following the methodology developed by Anderson et al.,
1999 [35]. Amplicon length variation of the PCR products was determined by CEQ 8000
Genetic analysis System (Beckman Coulter) using CEQ DNA Size Standard 400/600 as internal
size standards and CEQ 8000 software for fragment analysis. The reported allele size was
adjusted after comparison with reference alleles for each identified size in each locus. The exact
sizes of the reference alleles were previously determined by direct sequencing.
Microsatellite data and population genetic analyses
For each locus in each individual isolate, the predominant allele (where multiple alleles were
detected) or the only allele (where only a single allele was scored) were counted for population
genetic analyses. The predominant allele is defined as the highest peak in electropherogram
traces.
Genetic variation for each MS locus in each population was assessed by calculating both the
number of alleles per locus (A) and the expected heterozygosity (HE) from haploid data, as fol-
lows: HE = [n/(n − 1)](1 − ∑pi
2), where n is the number of isolates analyzed and p represents
the frequency of each different allele at a locus. The potential range is fromHE = 0 (no allele
diversity) toHE = 1 (all sampled alleles are different). For isolates that were fully genotyped at
all P. vivax and P. falciparum loci, analysis of multilocus linkage disequilibrium (LD) (non-ran-
dom associations among loci) was assessed using the standardized index of association (ISA).
Fig 1. Map of the five endemic study areas that participated in the PregVax project.
doi:10.1371/journal.pone.0152447.g001
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Differences of the estimated meanHE for each population and I
S
A were calculated using the
LIAN 3.5 software [36]. Additionally, allelic richness (Rs), which is a measure of the number of
alleles independent of sample size, was estimated per each country using FSTAT software
v2.9.3.2 [37]. Genetic differentiation between populations (FST) was estimated using Wright's F
statistics, and calculations were computed by Arlequin 3.5 [38]. Differences between the mean
HE of any two groups for each country was assessed using the Mann-Whitney U test. Differ-
ences were considered significant if the calculated p value was0.05 (two-tailed test).
Results
Complete results for all P. vivax and P. falciparumMS analyzed loci are shown as supporting
information in S1 Dataset. Most part of missing MSs data was linked to the high percentage of
the P. vivax and P. falciparum submicroscopic infections detected in the analyzed sample subset.
Genetic diversity and differentiation among Plasmodium vivax
populations
A total of 88 P. vivax isolates from Brazil, 47 from Colombia, 21 from India and 73 from Papua
New Guinea were typed for MS loci 1 to 7 (S1 Dataset). All the isolates from Colombia, India,
Papua New Guinea, and 37 isolates from Brazil were collected from pregnant women at the time
of ANC visits or at delivery. Fifty-one isolates from were obtained from non-pregnant women.
Full allelic data for all 7 MS loci were obtained for 133 of the total 229 analyzed P. vivax iso-
lates (Table 1), leading to the identification of 129 different haplotypes, with none of the haplo-
types shared between the parasite populations of the four endemic settings. The total number
of distinct alleles observed per locus ranged from a total of 35 for MS8 to 10 for MS1 and MS3,
with an overall mean of 23.1 alleles/ locus and a mean value of 11 alleles/country. Strong
genetic diversity and high values of allelic richness were observed across all analyzed study
sites. In particular, the isolates from India revealed the greatest level of genetic diversity (mean
HE = 0.855) whereas the lowest one was observed in Papua New Guinea (mean HE = 0.834)
(Fig 2). The isolates from Brazil showed the highest mean value of allelic richness (mean
Rs = 12.02). In particular, Brazilian isolates from the non-pregnant group (N = 37; HE = 0.841)
displayed a mean Rs value of 8.94, whereas isolates from pregnant group (N = 11,HE = 0.805)
showed an Rs value of 6.28 (S4 Table).
Table 1. Allelic richness (Rs) and LD (ISA) of analyzed Plasmodium vivax populations.
Country No. of isolates* No. of haplotypes Mean no. of alleles Rs§ IA
S (p#)
Brazil 88/48 (50%) 46 14.1 12.02 0.0648
(< 0.0001)
Colombia 47/22 (46.8%) 22 10.1 10.13 0.0272
(0.0629)
India 21/21 (100%) 21 9.8 9.85 0.0739
(0.0005)
PNG 73/42 (57.5%) 40 10.7 9.59 0.0405
(<0.0001)
* Number of isolates genotyped for at least 1 MS / number of isolates fully genotyped at all 7 MS loci (%)
§ Rs mean is based on minimum sample size of 21 individuals
# LD (ISA) is considered signiﬁcant when p value is 0.05
doi:10.1371/journal.pone.0152447.t001
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We compared the meanHE values from Brazilian pregnant and non-pregnant groups but
no significant difference was found (Mann-Whitney U test, p = 0.898); similarly, no significant
difference (p = 0.126) was found comparing Rs values from the same subgroups.
The analyzed P. vivax populations showed a significant LD (ISA> 0; p< 0.001) at multiple
loci in each population except for the case of Colombia (p = 0.062). A moderate degree of LD
was observed in Brazil, India and Papua New Guinea (Table 1).
Levels of genetic differentiation between each possible pair of the four parasite populations
are indicated by FST values in Table 2. All values were significantly different from 0 (p< 0.05).
We observed the highest differentiation between Colombia and Papua New Guinea (FST =
0.102), whereas India and Brazil displayed the lowest value (FST = 0.045) of the analyzed vivax
populations.
Fig 2. Genetic diversity (HE) of analyzed P. vivax and P. falciparum populations.
doi:10.1371/journal.pone.0152447.g002
Table 2. Genetic distance (FST) between P. vivax populations across study sites.
FST*
Country Brazil Colombia India
Brazil - - -
Colombia 0.06853 - - -
India 0.04540 0.07859 - - -
PNG 0.09109 0.10264 0.06485
FST*: all values resulting from the pairwise comparison of each country are signiﬁcant (p < 0.05)
doi:10.1371/journal.pone.0152447.t002
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Genetic diversity and differentiation among Plasmodium falciparum
populations
P. falciparum populations were also investigated in three of the study sites for comparison at
six MS loci. The genotyping was performed in 137 P. falciparum positive blood samples
obtained from pregnant women in Brazil (n = 15), Colombia (n = 50) and Papua New Guinea
(n = 72) (S1 Dataset) and, among these, a total of 66 isolates were fully genotyped as shown in
Table 3. None of the total 55 identified haplotypes were shared among the three P. falciparum
parasite populations. Estimates of HE and Rs per country were calculated (Table 3, Fig 2). The
highest estimates of genetic diversity were observed in samples obtained from pregnant women
in Papua New Guinea and the lowest in Colombia. Comparing the mean number of alleles and
Rs values obtained in Brazil with whose obtained in Colombia, we found similar values, even if
the P. falciparum populations from Brazil revealed a slightly higher of genetic diversity. Among
P. falciparum analyzed MS loci, locus TA60 showed the same two alleles in the total 50 isolates
from Colombia and in the total 15 isolates from Brazil. Additionally, locus TA60 displayed a
monomorphic allele in all 27 fully typed Colombian isolates. No LD, measured by ISA index,
was observed in Papua New Guinea (ISA> 0.0232; p = 0.06) while a significantly high LD value
was found both in Brazil and Colombia (Table 3), however, the small number of tested isolates
from Brazil (n = 8) may produce a biased ISA value.
The greatest value of inter-population differentiation (FST = 0.252, p< 0.05) was found
between Brazil and Colombia. In Papua New Guinea isolates displayed a moderate level of sig-
nificant differentiation, about 14.7% and 12.9% of the variation found in the Brazil and Colom-
bia populations, respectively (Table 4).
Comparison of haplotypes from different time points and compartments
Complete genotyping data were also obtained for isolates collected from successive samples
during the follow up of 9 pregnant women with P. vivax infection. In particular, in 4 infected
Table 3. Allelic richness (Rs) and LD (ISA) of analyzed Plasmodium falciparum populations.
Country No. of isolates* No. of haplotypes Mean no. of alleles Rs§ ISA (p#)
Brazil 15/8 (53.3%) 8 3.8 3.8 0.1718 (0.0094)
Colombia 50/27 (54%) 20 3.5 3.1 0.0354 (0.0292)
PNG 72/31 (43%) 27 6.3 5 0.0232 (0.0607)
* Number of isolates genotyped for at least 1 MS / number of isolates fully genotyped at all 6 MS loci (%)
§ Rs mean is based on minimum samples size of 8 individuals
#LD (IS A) is considered signiﬁcant when p value is 0,05
doi:10.1371/journal.pone.0152447.t003
Table 4. Genetic distance (FST) between Plasmodium falciparum populations from three analyzed
countries.
Country FST*
Brazil Colombia
Brazil - - -
Colombia 0.25216 - - -
PNG 0.14781 0.12901
FST*: all values resulting from the pairwise comparison of each country are signiﬁcant (p < 0.05)
doi:10.1371/journal.pone.0152447.t004
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women from Colombia and in 2 from Papua New Guinea, a distinct parasite haplotype was
detected in each of the subsequent episodes that occurred between 4 to 9 weeks after the first
episode. In 2 infected women from Colombia (by comparing 6 MS loci successfully genotyped)
and in 1 from Brazil the same haplotype was identified in subsequent episodes occurring at 3,
11 and 17 weeks.
In addition, parasite haplotypes from maternal peripheral blood at delivery and the placenta
were compared in 4 women (2 from Colombia and 2 from Papua New Guinea) infected with P.
falciparum infection. In all cases, parasites from maternal and placental blood had an identical
MS profile.
Genetic diversity according to Plasmodium species, age and parity of
the host
Only in Colombia we detected a significantly higher meanHE value among pregnant women
infected with P. vivax compared to those with P. falciparum infection (Mann-Whitney U test,
p = 0.027). Additionally, the genetic diversity of Plasmodium isolates according to age, parity,
parasitaemia (microscopic or submicroscopic) and presence of fever (37.5°C) among the
infected women were compared (sample size for each compartment is shown in S5 Table). In
Brazil, a significantly higher genetic diversity was observed in P. vivax parasites infecting multi-
gravidae (p = 0.003), those 25 years old (p = 0.009) and those who were afebrile (p = 0.015),
compared to primigravidae, those aged 11–20 years old and febrile women, respectively. In
contrast, P. falciparum parasites infecting 25 years old (p = 0.003) and those who were afe-
brile (p = 0.032), showed a significantly lower genetic diversity, while significant difference was
not observed in the genetic diversity level for other analyzed subgroups and countries. In
Colombia, the situation was exactly the opposite of what was observed in Brazil, but the differ-
ences in HE values were not statistically significant. In Papua New Guinea, the genetic diversity
was very similar in each age class for both vivax and falciparum, and the slight differences
observed were not significant in Mann-Whitney U test.
Discussion
This study was aimed at characterizing the genetic diversity of P. vivax populations in blood
samples obtained from pregnant women across different endemic areas by MS analysis. Over-
all, a wide range of short tandem repeat variants and high level of diversity in P. vivax and also
P. falciparum were observed. In particular, for each of the countries included in the study, the
diversity of P. vivax populations was slightly higher than for P. falciparum populations, though
a significant difference between HE values for the two species was only found in Colombian
isolates.
By evaluating these data according to the level of malaria endemicity, we know that the
investigated areas in Colombia and India show a low level of endemicity; Manaus, in Brazil, is
considered mesoendemic whereas Madang (Papua New Guinea) is the only area with a high
level of endemicity. P. falciparum populations show a direct association between the genetic
diversity and transmission intensity. However, the situation for P. vivax is more complicated
with observations showing high genetic diversity in parasite populations from low transmission
settings [9–16]. Findings of the present study relevant to the level of genetic diversity per coun-
try/per species (Fig 2), are consistent with what has been reported so far in the literature.
Indeed, falciparum population from Papua New Guinea (hyperendemic country) showed the
highest value of HE in comparison with the other populations studied, while high values of HE
were found in vivax populations from India and Colombia (hypoendemic) and Brazil (mesoen-
demic), confirming that this parasite is able to maintain a high degree of genetic variability
P. vivaxGenotyping in Different Endemic Settings
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irrespective of the transmission situation of its endemic area. Actually, the lowest HE value
among the vivax population included in this study was found in the parasite population from
Papua New Guinea, which happens to be the country with a high malaria transmission
intensity.
Based on previously defined range of genetic differentiation [39–40], almost all P. vivax
populations examined showed moderate level of differentiation ranging from about 6.4% to
10.2% (FST pairwise analysis). On the contrary, falciparum populations showed to be highly
differentiated from each other in the pairwise comparison between countries (FST, from 12.9%
to 25.2%); parasites from the two geographically closer Southern American countries, Brazil
and Colombia, appeared to be the most divergent according to the FST analysis (25.2%). Our
result is consistent with the independent origins of these two parasite populations, as shown by
Yalcindag et al (2012) [41]. Indeed, the authors speculated that South American P. falciparum
populations are subdivided into two main genetic clusters: northern (including Colombia) and
southern (Brazil, Bolivia and French Guiana), due to two different introduction events during
European colonization.
Moreover, the study allowed comparison of genetic variability according to parity, age, level
of parasitaemia, or presence of fever both in P. vivax and P. falciparum populations from Brazil,
Colombia and Papua New Guinea. Interestingly, for the P. vivax population from Brazil, we
have noticed that older age was associated with a significant increase inHE values, whereas for
the Brazilian P. falciparum population an inverse relationship to age was observed. A possible
explanation for this opposite trend in the two Plasmodium species might be that the different
level of endemicity for P. vivax and P. falciparum populations could result in differences in
reaching acquired immunity (in most of P. vivax low endemic areas this is rarely achieved even
during the course of a lifetime [42]) and this, in turn, could affect the number of plasmodial
clones circulating in a given area and hence the level of parasite genetic diversity. A decrease of
genetic diversity with older age has been already observed in P. falciparum populations and
reported in previous studies carried out in Sudan and Central African Republic [43, 44]. In
Colombia, the situation was exactly the opposite of what was observed in Brazil, but the differ-
ences in HE values were not statistically significant. In Papua New Guinea, the genetic diversity
was very similar in each age class for both vivax and falciparum, and the slight differences
observed were not significant.
Malaria infection in pregnancy is associated with high risk of both maternal and perinatal
morbidity and mortality. It is recognized that pregnant women have a reduced immune
response and therefore clear malaria parasites with difficulty and are more exposed to the
severe form of the diseases [45]. In our study, only in Brazil it was possible to investigate
whether Plasmodium isolates detected in pregnant infected women could show different geno-
typic characteristics compared to non-pregnant women. High HE values were observed in the
Brazilian P. vivax populations both from pregnant (0.805) and non-pregnant (0.841) infected
women and the differences between the twoHE values were not statistically significant. Similar
findings have been recently described in Colombia [31]. The observed LD values were quite dif-
ferent however the vivax populations from pregnant women included a small number of sam-
ples (n = 11), which may have affected the evaluation of LD in this subpopulation.
By genotyping nine patients with subsequent P. vivax episodes, we observed that the geno-
type of the parasites of the admission episode can differ or can be identical to the genotype of
the subsequent episode and that these results are in line to what was reported in previous stud-
ies [46–49]. Hence, in the attempt to distinguish between relapses, recrudescences and new
infections, the level of transmission in the area, the treatment regimen received and the time
intervals between the episodes have to be taken into account together with the results of genetic
characterization of parasite isolates [47]. In our study we observed four subsequent episodes in
P. vivaxGenotyping in Different Endemic Settings
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four Colombian patients that can be attributable to relapses. In these patients, the isolate identi-
fied in the admission episode had a different MS haplotype compared to that one identified in
the corresponding subsequent episode. Taking into account the level of malaria endemicity in
Colombia (hypoendemicity) as well as the time interval between the admission episode and the
subsequent episode, we can assume that the four patients had relapses due the activation of
latent hypnozoites, showing a different haplotype rather than a new infection.
In the frame of Pregvax project, we have also identified and genotyped two cases of congeni-
tal malaria, a case in a woman from Guatemala infected with P. vivax (see reference [50]) and a
case in a woman from Papua New Guinea, infected with P. falciparum. In both cases, identical
parasite haplotypes in maternal peripheral blood at delivery and in the placental, cord and
newborn peripheral blood were found. In our knowledge, these are the only two cases where
mother-to-child malaria transmission has been confirmed by means of MS analysis.
The findings of this study confirm the usefulness of MS analysis as a genetic tool for investi-
gating P. vivax and P. falciparum population structures. As already reported in previous similar
studies [9, 28, 29, 51], P. vivax populations were more diverse than those of P. falciparum and
in some of the studied countries, the diversity of P. vivax populations was striking compared to
the respective level of endemicity. Molecular surveillance of the Plasmodium genetic variability
is of great importance in the context of malaria containment efforts, since a correct and exten-
sive appraisal of the genetic makeup of plasmodial populations is crucial in the identification of
the most adequate control strategies, particularly in countries that are in the pathway towards
malaria elimination. In the last few years, many studies have included the investigation of the
genetic variability of P. vivax isolates through the analysis of the MS diversity, however, those
including these analysis in pregnancy are scarce [31,32]. For this reason the present study,
which included samples mainly from pregnant women, from endemic areas of four different
countries, could contribute to increasing the knowledge on the genetic diversity of parasite
populations of this important but still neglected human malaria parasite.
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